AAQL · XBRL financial data
Antiaging Quantum Living financial statements, every fiscal year
The same tables from 8 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (AAQL's year ends in late March)
| In thousands of dollars | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | Mar 31, 2025 | Mar 31, 2026 |
|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 4 | 7 | 14 | 7 | 818 | 1,034 |
| Cost of revenue | 1 | 1 | — | 1 | 389 | 332 |
| Gross profit | 3 | 6 | 14 | 7 | 429 | 702 |
| General and administrative | 76 | 51 | 50 | 349 | 1,060 | 1,377 |
| Total operating expenses | 76 | 51 | 50 | 420 | 1,218 | 1,538 |
| Operating income (loss) | (73) | (45) | (37) | (413) | (790) | (835) |
| Other income (expense) | 1 | — | — | 0 | 69 | — |
| Income tax expense (benefit) | — | — | — | — | — | 17 |
| Net income (loss) | (67) | (43) | (37) | (413) | (720) | (838) |
| Earnings per share, basic USD per share | (0.00) | (0.00) | (0.00) | (0.01) | (0.02) | (0.03) |
| Earnings per share, diluted USD per share | — | — | — | (0.01) | (0.02) | (0.03) |
| Weighted average shares, basic thousands of shares | 29,995 | 29,995 | 29,995 | 29,995 | 29,995 | 31,484 |
| Weighted average shares, diluted thousands of shares | — | — | 29,995 | 29,995 | 29,995 | 31,484 |
Balance sheet
CSVFiscal years (AAQL's year ends in late March)
| In thousands of dollars | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | Mar 31, 2025 | Mar 31, 2026 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 17 | 14 | 0 | 167 | 371 | 503 |
| Accounts receivable | — | — | — | 2 | 86 | 30 |
| Inventory | — | — | — | — | — | 219 |
| Total current assets | 68 | 14 | 0 | 224 | 811 | 1,214 |
| Property and equipment, net | — | 1 | 1 | 216 | 121 | 148 |
| Right-of-use asset | — | — | — | 540 | 645 | 348 |
| Total assets | 68 | 15 | 1 | 1,012 | 1,589 | 1,723 |
| Accounts payable | — | — | 1 | — | — | — |
| Accrued liabilities | — | — | 1 | — | — | — |
| Total current liabilities | 74 | 65 | 87 | 871 | 678 | 1,673 |
| Lease liability, non-current | — | — | — | 135 | 367 | 320 |
| Total liabilities | 74 | 65 | 87 | 1,426 | 2,719 | 2,399 |
| Accumulated deficit | (196) | (240) | (276) | (689) | (1,410) | (2,247) |
| Total stockholders' equity | (6) | (49) | (86) | (413) | (1,130) | (676) |
| Total liabilities and equity | 68 | 15 | 1 | 1,012 | 1,589 | 1,723 |
| Common shares outstanding (cover page) thousands of shares | 29,995 | 29,995 | 29,995 | 29,995 | 29,995 | 34,275 |
Cash flows
CSVFiscal years (AAQL's year ends in late March)
| In thousands of dollars | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | Mar 31, 2025 | Mar 31, 2026 |
|---|---|---|---|---|---|---|
| Net income (loss) | (67) | (43) | (37) | (413) | (720) | (838) |
| Depreciation and amortization | — | — | 0 | 7 | 144 | 135 |
| Net cash from operating activities | (64) | (41) | (38) | (649) | (900) | (171) |
| Purchases of property and equipment | — | 1 | — | — | — | — |
| Net cash from investing activities | 20 | 50 | — | (224) | (63) | (162) |
| Net cash from financing activities | — | (12) | 24 | 1,040 | 1,168 | 460 |
| Net change in cash | (44) | (3) | (14) | — | — | — |
Compare with peers
SIC 7331 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.
How peers are chosen
- SIC 7331 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Fewer than three companies fall in that range, so the list adds same-SIC (7331) companies nearest in public float, each marked “added: same SIC”.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Antiaging Quantum Living | 608 | 730 | (472) | 34.3M | 1.3 quarters | 10-QJun 30, 2026 |
| Harte Hanksadded: same SIC | 5,185 | 37,984 | (2,072)* | 7.5M | 2.5 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.